Efficacy and Safety of the Combination of Transarterial Chemoembolization with Camrelizumab plus Apatinib for Advanced Hepatocellular Carcinoma: A Retrospective Study of 38 Patients from a Single Center

OBJECTIVE: To evaluate the effectiveness and safety of transarterial chemoembolization (TACE) combined with immune checkpoint inhibition (camrelizumab) plus an antiangiogenic agent (apatinib) for advanced hepatocellular carcinoma (HCC). METHODS: Between March 2019 and April 2021, the clinical data o...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jin-Xing, Chen, Yu-Xing, Zhou, Chun-Gao, Liu, Jin, Liu, Sheng, Shi, Hai-Bin, Zu, Qing-Quan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110252/
https://www.ncbi.nlm.nih.gov/pubmed/35586608
http://dx.doi.org/10.1155/2022/7982118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110252/
https://www.ncbi.nlm.nih.gov/pubmed/35586608
http://dx.doi.org/10.1155/2022/7982118

Ejemplares similares